Phase 3 Attracts Two Leases at Waltham Lab Building
Two Greater Boston biotechs leased a combined 48,127 square feet at a Waltham life science property owned by Phase 3 Real Estate partners and Bain Capital Real Estate.
Two Greater Boston biotechs leased a combined 48,127 square feet at a Waltham life science property owned by Phase 3 Real Estate partners and Bain Capital Real Estate.
An award-winning life science development in Cambridge was acquired by Phase 3 Real Estate Partners for $25 million.
A developer that specializes in office to lab conversions secured the largest life science lease of 2025 in Boston with a four-year-old company founded by Harvard University researchers.
A South Boston office property once eyed for multifamily housing has been acquired by a lab developer for $23.5 million.
A high-visibility Downtown Crossing office building could become one of Boston’s next lab conversions following a $107-million acquisition.
A pair of Fort Point office buildings have been moved into Boston’s life science pipeline after one was sold and conversion plans for another were filed with city officials.
San Diego-based life science developer Phase 3 Real Estate Partners has acquired a pair of properties in Watertown and South Boston for $81.2 million.